Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05146336 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

CytOSorb TreatMent Of Critically Ill PatientS Registry

Study acronym: COSMOS
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Site contacts updated at 2 of 28 sitesv32
  2. Study sites: 27 to 28v31
  3. Site contacts updated at 1 of 27 sitesv30
  4. Study sites: 26 to 27v29
  5. Study sites: 25 to 26v28
Show 26 earlier versionsHide 26 earlier versions
  1. Study sites: 23 to 25v27
  2. Study sites: 22 to 23v26
  3. Site details revised at 1 of 22 sitesv25
  4. Study sites: 21 to 22v24
  5. Study sites revised (21)v23
  6. Study sites: 18 to 21v22
  7. Study sites: 17 to 18v21
  8. Primary completion date: Mar 2031 to Jun 2032
    • Study completion date: Jun 2031 to Sep 2032
    • Eligibility criteria expanded, about 51 words
    • Site details revised at 1 of 17 sites
    v20
  9. Study sites revised (17)v19
  10. Site details revised at 1 of 17 sitesv18
  11. Study sites: 16 to 17v17
  12. Site details revised at 1 of 16 sitesv16
  13. Study sites: 15 to 16v15
  14. Study sites: 14 to 15v14
  15. Study sites: 10 to 14v13
  16. Study sites: 7 to 10v12
  17. Study sites: 6 to 7v11
  18. Study sites: 5 to 6v10
  19. Study sites: 3 to 5v9
  20. Site details revised at 1 of 3 sites
    • Eligibility criteria expanded, about 3 words
    v8
  21. Study sites: 2 to 3v7
  22. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Aug 2022 to Jun 22, 2022
    • Site details revised at 2 of 2 sites
    v6
  23. Start date: Jun 2022 to Aug 2022v5
  24. Site contacts updated at 1 of 2 sitesv4
  25. Site contacts updated at 1 of 2 sitesv3
  26. Start date: Mar 2022 to Jun 2022
    • Study sites: 0 to 2
    v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Registry intended to provide a data repository and reporting infrastructure for the surveillance of CytoSorb device use in real-world critical care settings, and to serve as an objective, comprehensive, and scientifically-based resource to measure and improve the quality of patient care
Trial Details
NCT Number NCT05146336
Lead Sponsor CytoSorbents, Inc
Conditions
(from sponsor)		 Septic Shock, Acute Respiratory Distress Syndrome, Trauma, Rhabdomyolysis, Cardiogenic Shock, Pancreatitis, Acute on Chronic Liver Failure, Acute Liver Failure +10 more
Related terms Acute-On-Chronic Liver Failure, Burns, Communicable Diseases, Cytokine Release Syndrome, Drug Overdose, Liver Failure, Acute, Lymphohistiocytosis, Hemophagocytic, Pancreatitis, Respiratory Distress Syndrome, Rhabdomyolysis, Sepsis, Shock, Cardiogenic, Shock, Septic, Vasoplegia, Wounds and Injuries
Enrollment 3,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov